Gyeonggi-do, South Korea

Ho Youl Lee

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Sk Biopharmaceuticals Co., Ltd., Sk Biopharmaceuticals., Ltd.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ho Youl Lee. Retrieved from https://idiyas.com/inventor/ho-youl-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ho Youl Lee: Innovator in Bicyclic Compounds

Introduction

Ho Youl Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of bicyclic compounds. With a total of 4 patents to his name, Lee is recognized for his innovative approaches to treating diseases linked to PRMT5.

Latest Patents

Lee's latest patents focus on bicyclic compounds that serve as PRMT5 inhibitors. The first patent describes a 6-6 bicyclic ring-containing compound derivative, which can be effectively used in the prevention or treatment of diseases caused by PRMT5. The second patent details a compound derivative containing a 6-7 bicyclic ring, also aimed at inhibiting PRMT5 and addressing related health issues. These inventions highlight Lee's commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Ho Youl Lee is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has garnered attention for its potential impact on therapeutic strategies for diseases associated with PRMT5. Lee's expertise in bicyclic compounds positions him as a key player in the biopharmaceutical industry.

Collaborations

Lee collaborates with talented professionals in his field, including Jin Hee Kim and Jun Youb Lee. These partnerships enhance the research and development efforts at Sk Biopharmaceuticals Co., Ltd., fostering an environment of innovation and discovery.

Conclusion

Ho Youl Lee's contributions to the field of biopharmaceuticals through his innovative bicyclic compounds demonstrate his dedication to improving healthcare solutions. His work not only showcases his inventive spirit but also holds promise for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…